Literature DB >> 7659648

Clinical pattern of cutaneous drug eruption among children and adolescents in north India.

V K Sharma1, S Dhar.   

Abstract

Various types of cutaneous drug eruptions and the incriminating drugs were analyzed in 50 children and adolescents up to 18 years of age (34 or 65% boys, 16 or 32% girls). Thirteen (26%) patients had a maculopapular rash, 11 (22%) a fixed drug eruption (FDE), 10 erythema multiforme (EM), 6 (12%) toxic epidermal necrolysis (TEN), 5 (10%) Stevens-Johnson syndrome (SJS), 3 (6%) urticaria, and 2 (4%) erythroderma. The incubation period for maculopapular rashes, SJS and TEN due to commonly used antibiotics and sulfonamides was short, a few hours to two to three days, reflecting reexposure, and for drugs used sparingly such as antiepileptics and antituberculosis agents, was approximately one week or more, suggesting a first exposure. Antibiotics were responsible for cutaneous eruptions in 27 patients, followed by antiepileptics in 17, analgin in 4, and metronidazole and albendazole in 1 each. Cotrimoxazole, a combination of sulfamethoxazole and trimethoprim, was the most common antibacterial responsible for eruptions (11 patients), followed by penicillin and its semisynthetic derivatives (8 patients), sulfonamide alone (3 patients), and other antibiotics (4 patients). Antiepileptics were the most frequently incriminated drugs in EM, TEN, and SJS. The role of systemic corticosteroids in the management of SJS and TEN is controversial. We administered prednisolone or an equivalent corticosteroid 2 mg/kg/day for 7 to 14 days.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7659648     DOI: 10.1111/j.1525-1470.1995.tb00149.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  11 in total

Review 1.  Recognising antibacterial hypersensitivity in children.

Authors:  A Romano
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.022

Review 2.  Cutaneous drug reactions in children: an update.

Authors:  Kara Heelan; Neil H Shear
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

Review 3.  Management of cutaneous drug reactions.

Authors:  K S Babu; Geeta Belgi
Journal:  Curr Allergy Asthma Rep       Date:  2002-01       Impact factor: 4.919

4.  Causative Drugs and Clinical Outcome in Stevens Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and SJS-TEN Overlap in Children.

Authors:  Gomathy Sethuraman; Vinod K Sharma; Pooja Pahwa; Pooja Khetan
Journal:  Indian J Dermatol       Date:  2012-05       Impact factor: 1.494

5.  Mild cutaneous reactions to drugs.

Authors:  Giuseppe Crisafulli; Fabrizio Franceschini; Silvia Caimmi; Paolo Bottau; Lucia Liotti; Francesca Saretta; Roberto Bernardini; Fabio Cardinale; Francesca Mori; Carlo Caffarelli
Journal:  Acta Biomed       Date:  2019-01-28

6.  Cutaneous adverse drug reaction profile in a tertiary care out patient setting in eastern India.

Authors:  Abanti Saha; Nilay Kanti Das; Avijit Hazra; Ramesh Chandra Gharami; Satyendra Nath Chowdhury; Pijush Kanti Datta
Journal:  Indian J Pharmacol       Date:  2012 Nov-Dec       Impact factor: 1.200

7.  Psoriasiform drug eruption associated with sodium valproate.

Authors:  Gulen Gul Mert; Faruk Incecik; Suhan Gunasti; Ozlem Herguner; Sakir Altunbasak
Journal:  Case Rep Pediatr       Date:  2013-11-13

8.  Clinical features of fixed drug eruption at a tertiary hospital in Korea.

Authors:  Jae-Woo Jung; Sang-Heon Cho; Kyu-Han Kim; Kyung-Up Min; Hye-Ryun Kang
Journal:  Allergy Asthma Immunol Res       Date:  2014-03-26       Impact factor: 5.764

9.  Fixed Drug Eruption due to Achiote Dye.

Authors:  Ian Tattersall; Bobby Y Reddy
Journal:  Case Rep Dermatol       Date:  2016-01-28

10.  Fixed-drug Eruptions: What can we Learn from a Case Series?

Authors:  Ratinder Jhaj; Deepa Chaudhary; Dinesh Asati; Balakrishnan Sadasivam
Journal:  Indian J Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.